EDGAR Filing Documents for 0001193125-06-056576

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:

SEC Accession No. 0001193125-06-056576

Filing Date

2006-03-16

Accepted

2006-03-16 15:25:27

Documents

Period of Report

2005-12-31

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 10-K	d10k.htm	10-K	1426428
2	AMENDED AND RESTATED CO-DEVELOPEMENT AND COMMERCIALIZATION AGREEMENT	dex1054.htm	EX-10.54	653166
3	SECOND AMENDED AND RESTATED WORLDWIDE AGREEMENT	dex1055.htm	EX-10.55	306779
4	AMENDED AND RESTATED CONSULTING AGREEMENT	dex1056.htm	EX-10.56	36014
5	CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM	dex231.htm	EX-23.1	9073
6	CERTIFICATION OF PEO PURSUANT TO RULE 13A-14(A) AND RULE 15D-14(A)	dex311.htm	EX-31.1	5944
7	CERTIFICATION OF PAO PURSUANT TO RULE 13A-14(A) AND RULE 15D-14(A)	dex312.htm	EX-31.2	5998
8	CERTIFICATION OF PEO AND PAO PURSUANT TO RULE 13A-14(B) AND RULE 15D-14(B)	dex321.htm	EX-32.1	3360
9	GRAPHIC	g71066logo166.jpg	GRAPHIC	7882
	Complete submission text file	0001193125-06-056576.txt		2459263

Mailing Address 34801 CAMPUS DR FREMONT CA 94555

Business Address 34801 CAMPUS DR FREMONT CA 94555 5105741400

PDL BIOPHARMA, INC. (Filer) CIK: 0000882104 (see all company filings)